GRAIL News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.09.24	European Court Rules In Favor Of Illumina In Fight Against Probe Into Grail Deal, Asks Not To Pay $478M Fine (Benzinga)
03.09.24	EU’s top court sides with Illumina over probe into $8bn Grail acquisition (Financial Times)
25.06.24	Once Valued At Around $7B, Cancer Blood Test Developer Grail To Kickstart Trading On NASDAQ (Benzinga)
18.06.24	US biotech Illumina faces potential $7bn loss from forced Grail sale (Financial Times)
18.06.24	US biotech Illumina faces steep loss from forced sale of Grail (Financial Times)
08.06.24	Scientists Inch Closer to the Holy Grail of Clean Energy (OilPrice.com)
25.04.24	Mark Zuckerberg Shifts Meta's Focus To AI 'Agents' Over Chatbots: Apple To Pursue Similar 'Holy Grail,' Predicts Gene Munster (Benzinga)
22.03.24	Policymakers convinced holy grail of ‘immaculate disinflation’ within reach (Financial Times)
21.03.24	EU Antitrust Regulators Overstepped in Illumina-Grail Deal, Says Court Adviser (Benzinga)
21.03.24	EU wrong to block Illumina’s $8bn takeover of Grail, says court adviser (Financial Times)
21.03.24	Scientists inch towards holy grail of fusion reactors (Financial Times)
15.03.24	The Race for The Holy Grail of EV Batteries Heats Up (OilPrice.com)
13.03.24	Gene Sequencing Firm Illumina Escapes Carl Icahn's Second Proxy Battle Amid Grail Divestment Efforts (Benzinga)
08.03.24	MAGA, YODA and BRRR - The quest for catchy ETF tickers (Financial Times)
12.02.24	Novo Nordisk, Eli Lilly Stride To Boost Supply Shortage For Newly Found Holy Grail Of Miraculous Weight Loss Drugs (Benzinga)
09.02.24	DNA Sequencing Kit Provider Illumina's Q4 Earnings Edge Above Street Estimates, Works To Resolve GRAIL Quickly (Benzinga)
16.01.24	Investors chase the grail of unravelling AI’s mysteries (Financial Times)
19.12.23	Carl Icahn Escalates Boardroom Battle At Illumina, Seeks To Remove More Directors After Grail Divestiture (Benzinga)
18.12.23	Illumina-Grail $8B Saga Ends After It Battles Regulators For 3 Years (Benzinga)
17.12.23	Illumina to sell cancer-test maker Grail after latest antitrust ruling (MarketWatch)
13.12.23	Tesla Shares Hardly Damaged Despite Recall: Full Self-Driving Is Elon Musk's 'Holy Grail,' Analyst Says (Benzinga)
12.12.23	Illumina Versus European Commission: Legal Battle Over Grail Acquisition Reaches Critical Stage (Benzinga)
13.07.22	Illumina-Aktie schwächer: EU-Gericht beurteilt Kartellprüfung von GRAIL-Deal als rechtens (Dow Jones) Die Entscheidung der EU-Wettbewerbsbehörde, die milliardenschwere Übernahme des Testentwicklers GRAIL durch das US-Unternehmen Illumina zu prüfen, ist rechtens, auch wenn die Transaktion nicht die traditionellen Kriterien für eine Prüfung erfüllt.» mehr

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Geberit	529.60	0.84 %	K V
ABB	49.84	0.73 %	K V
Part Grp Hldg	1’273.00	0.55 %	K V
Lonza Grp	523.20	0.54 %	K V
UBS Group	28.19	0.39 %	K V
Swisscom	509.00	-0.20 %	K V
Kuehne+Nagel Int	209.70	-0.24 %	K V
Swiss Re	129.55	-0.38 %	K V
Nestle	76.26	-0.50 %	K V
Swiss Life Hldg	716.40	-0.72 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu GRAIL

Aktien Top/Flop

GRAIL Peer Group Nachrichten

Meistgelesene Nachrichten